Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 152,800 shares, a decrease of 36.9% from the February 28th total of 242,000 shares. Approximately 3.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is presently 0.1 days.

Check-Cap Price Performance

CHEK traded down $0.01 on Monday, hitting $0.78. 3,814 shares of the stock were exchanged, compared to its average volume of 365,095. Check-Cap has a 12 month low of $0.56 and a 12 month high of $3.10. The firm has a market capitalization of $4.56 million, a price-to-earnings ratio of -0.26 and a beta of 0.19. The business has a 50-day moving average of $0.90 and a two-hundred day moving average of $1.08.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Check-Cap in a report on Tuesday, March 25th. They issued a “sell” rating for the company.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.